CALC
CalciMedica, Inc.
NASDAQ · Healthcare · Biotechnology · US
$1.92
−2.54%Next report
Analyst consensus
- Next report date
- Nov 11, 2026
- EPS estimate
- -$1.27
- Revenue estimate
- —
Latest reported
- Last report date
- Aug 11, 2026
- EPS actual
- -$0.45
- EPS estimate
- -$0.28
- Revenue actual
- —
- Revenue estimate
- —
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 7
- EPS misses (12Q)
- 4
- EPS in line (12Q)
- 1
- Avg surprise (4Q)
- -7.9%
- Revenue beats (12Q)
- —
No earnings call summaries available
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Aug 11, 2026 | -$0.28 | -$0.45 | Miss -57.89% | — |
| May 12, 2026 | -$0.28 | -$0.22 | Beat 21.43% | — |
| Nov 12, 2025 | -$0.41 | -$0.39 | Beat 4.88% | — |
| Aug 12, 2025 | -$0.40 | -$0.40 | In line | — |
| May 14, 2025 | -$0.43 | -$0.36 | Beat 16.28% | — |
| Mar 27, 2025 | -$0.48 | -$0.34 | Beat 29.17% | — |
| Nov 13, 2024 | -$0.61 | -$0.50 | Beat 18.03% | — |
| Nov 9, 2023 | -$1.14 | -$0.82 | Beat 28.07% | — |
| Aug 10, 2023 | -$1.02 | -$1.11 | Miss -8.82% | — |
| May 12, 2023 | -$0.73 | -$23 | Miss -3109.59% | — |
| Mar 9, 2023 | -$5.88 | -$4.79 | Beat 18.50% | — |
| Nov 10, 2022 | -$6.16 | -$6.44 | Miss -4.55% | — |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Nov 11, 2026